B
BIO
BIOVerified3 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$2.6B3.9%
FY2024
Operating Segments
3Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Clinical Diagnostics
Segment Shift
Clinical Diagnostics has grown from 64.0% to 59.9% of total revenue since FY2016, with 0.0% operating margins.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Clinical Diagnostics | $1.5B | $0 | 0.0% | 59.9% | +3.3% |
| Life Science | $1.0B | $0 | 0.0% | 40.1% | -12.8% |
| All Others | $500,000 | $0 | 0.0% | 0.0% | -86.1% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free